The agmdhope’s Podcast

August 2025 Virtual Gastroparesis Awareness Month Program Series Featuring Chris Quesenberry. In this program, Chris discusses Advocating for Gastroparesis – A Pharmaceutical Company’s Journey.

In this interview, Dr. Mark Pimentel discusses Irritable Bowel Syndrome. 

AGMD is honored to have Dr. Bolaji Ayinde present Functional Dyspepsia for our Neurogastroenterology and Motility Expert Series.

In this program, Dr. Sharma discusses Clues and Cues from the Neurogastroenterologist: Gastroparesis and Functional Dyspepsia in EDS.   Dr. Sharma is currently the Donald O. Castell Endowed Chair in Gastroenterology at the Medical University of South Carolina (MUSC). He has a clinical and translational focus in Neurogastroenterology & Motility (NGM), particularly diabetic gastroparesis and Parkinson’s disease. He obtained his medical degree at Virginia Commonwealth University, completed internal medicine residency at Temple University Hospitals, and GI fellowship at Penn State Hershey Medical Center. After completing training, he spent 10 years on faculty at the Medical College of Georgia. Dr. Sharma’s research focus is understanding the pathophysiology of gut-brain axis in various conditions and developing innovative, non-invasive, and promising neuromodulation therapies through his insights, mentorship and collaborations, and his engineering background. He currently serves as principal investigator of a NIH-funded multi-center, randomized, sham- controlled study investigating thoracic neuromodulation for diabetic gastroparesis (RO1-DK133520) and a MPI of a Gastroenterology-Neurology Research Centers of the Consortium of Gut-Brain Communication in Parkinson disease (U01- DK140923).

In this program, Chris discusses Advocating for Gastroparesis – A Pharmaceutical Company’s Journey. Chris is the Chief Commercial Officer at Evoke Pharma, Inc.

AGMD is proud to present our series featuring Dr. Kenneth Koch.  Every other month, we will be having a conversation with Dr. Koch and focusing on various topics related to gastroparesis.   This month, Dr. Koch will discuss the Differences Between Diabetic, Idiopathic, and Secondary Causes of Gastroparesis.   There will be ample time for questions towards the end of the program.   Kenneth L. Koch, MD is Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books.   Sponsored by the Association of Gastrointestinal Motility Disorders, Inc. AGMD  

AGMD is privileged to present our AGMD Conversations with Dr. Kenneth Koch, MD series. Every other month, we will be talking with Dr. Koch and focusing on various topics related to gastroparesis. August is Gastroparesis Awareness Month, and Dr. Koch answers questions about gastroparesis submitted by our audience participants. Kenneth L. Koch, MD, is a Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books. This program is sponsored by the Association of Gastrointestinal Motility Disorders, Inc. | AGMD |.

AGMD is proud to present our series featuring Dr. Kenneth Koch.  Every other month, we will be having a conversation with Dr. Koch and focusing on various topics related to gastroparesis.   This month, Dr. Koch will discuss Diagnostic Tests For Gastroparesis.   There will be ample time for questions towards the end of the program.   Kenneth L. Koch, MD is Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books.  

Laura A. Dotson is a native of North Carolina and a practicing interior designer. She graduated from Salem College, the University of North Carolina at Greensboro, and The Prince of Wales’s Institute of Architecture, with graduate work done at North Carolina University of Agriculture and Technical University.  Because of her own medical journey, she has become an advocate for those who suffer from nausea and vomiting for any reason.  Laura had her gallbladder removed. Immediately thereafter, she remained nauseated and would vomit 30-40 times per day.  Laura was misdiagnosed for a tormenting 18 months.  No one ought to live like that. Her collaboration with Dr. Kenneth L. Koch as co-author of Comforting Your Uncomfortable Stomach: A companion for the Silent Sufferers of Nausea and Vomiting is a result of her finding the exact doctor she needed. Laura was referred to Dr. Koch in 2004 and diagnosed with severe gastroparesis. She is now healed and determined to share her experience to propagate education, heighten public awareness, and fundraise for research about the life-altering, silent, and lonely illnesses from which millions suffer that include the symptoms of nausea and vomiting. Silent No More is her goal! Join us for this inspiration and informative program. You won't want to miss it!

AGMD is proud to present our series featuring Dr. Kenneth Koch.  Every other month, we will be having a conversation with Dr. Koch and focusing on various topics related to gastroparesis.   This month, Dr. Koch will discuss Diagnosing and Subtyping Gastroparesis.   There will be ample time for questions towards the end of the program.   Kenneth L. Koch, MD is Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books.   Sponsored by the Association of Gastrointestinal Motility Disorders, Inc. AGMD  

AGMD is proud to present our series featuring Dr. Kenneth Koch.  Every other month, we will be having a conversation with Dr. Koch and focusing on various topics related to gastroparesis.   This month, Dr. Koch will discuss Gastroparesis & Irritable Bowel Syndrome.   There will be ample time for questions towards the end of the program.   Kenneth L. Koch, MD is Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books.   Sponsored by the Association of Gastrointestinal Motility Disorders, Inc. AGMD

Michael’s life was changed once he was diagnosed with an anal fissure, fistula, and small bowel intestinal overgrowth (SIBO). His faith became strengthened, and his understanding of GI problems and their impact became eye-opening. Michael now has compassion for all those suffering from digestive diseases and disorders and has a deeper appreciation of health and life itself. Special thanks to Matthew Petrulavage for editing the recording.  Owner | Plus One Productions - DJ Petro Entertainment Music Producer & Live Event DJ/MC   Sponsored by the Association of Gastrointestinal Motility Disorders, Inc. | AGMD |    

AGMD is proud to present our series featuring Dr. Kenneth Koch.  Every other month, we will be having a conversation with Dr. Koch and focusing on various topics related to gastroparesis.   This month, we will be highlighting the autonomic nervous system, POTS, and gastroparesis.   There will be ample time for audience questions towards the end of the interview.   Kenneth L. Koch, MD is Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books.   This program is sponsored by the Association of Gastrointestinal Motility Disorders, Inc. | AGMD |  

AGMD is proud to present our Conversations with Dr. Kenneth Koch series.  Every other month, we will be having a conversation with Dr. Koch and focusing on various topics related to gastroparesis.   This month, we will be highlighting Gastroparesis and Functional Dyspepsia - Are They the Same or Different?   Kenneth L. Koch, MD is Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books.   This program is sponsored by the Association of Gastrointestinal Motility Disorders, Inc. | AGMD |. For more information, visit our website at www.agmdhope.org

AGMD is proud to present our series featuring Dr. Kenneth Koch.  Every other month, we have a conversation with Dr. Koch focusing on various topics related to gastroparesis.   August is Gastroparesis Awareness Month. We will be presenting a special program entitled, "Ask Dr. Koch."   During the program, Dr. Koch will respond to questions submitted by our audience participants.   Kenneth L. Koch, MD is Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books.

AGMD is proud to present our series featuring Dr. Kenneth Koch.  Every other month, we will be having a conversation with Dr. Koch and focusing on various topics related to gastroparesis.   This month, we will be highlighting the autonomic nervous system, POTS, and gastroparesis.   Kenneth L. Koch, MD is Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books.  

AGMD is proud to present our Conversations with Dr. Kenneth Koch series.  Every other month, we will be having a conversation with Dr. Koch and focusing on various topics related to gastroparesis.   This month, we will be highlighting Gastroparesis and Functional Dyspepsia - Are They the Same or Different?   Kenneth L. Koch, MD is Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books.

AGMD is proud to present a new series featuring Dr. Kenneth Koch.  Every other month, we will be having a conversation with Dr. Koch and focusing on various topics related to gastroparesis.   This month, we will be highlighting gastroparesis and pain.   There will be ample time for audience questions towards the end of the interview.   Kenneth L. Koch, MD is Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books.

AGMD is privileged to present a second Interview with Kenneth Koch, MD During this part II interview, Dr. Koch will be talking about gastroparesis. Towards the end of the program, there will be ample time for questions from the audience participants. Kenneth L. Koch, MD is Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books. This program is sponsored by the Association of Gastrointestinal Motility Disorders, Inc. | AGMD |.

AGMD is proud to present a new series featuring Dr. Kenneth Koch.  Every other month, we will be having a conversation with Dr. Koch and focusing on various topics related to gastroparesis.   This month, we will be discussing the vagus nerve, fundoplication and post surgical gastroparesis.   There will be ample time for audience questions towards the end of the interview.   Kenneth L. Koch, MD is Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books.

AGMD is privileged to present an Interview with Kenneth Koch, MD During the interview, Dr. Koch will be talking about gastroparesis. Towards the end of the program, there will be ample time for questions from the audience participants. Kenneth L. Koch, MD is Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books. This program is sponsored by the Association of Gastrointestinal Motility Disorders, Inc. | AGMD |.

AGMD is proud to present an Interview with Julie Bender-Sibbio, RDN, LDN, cWC. During the interview, Julie will talk about "Lifestyle Strategies to Support Your Immune System During COVID-19 and Beyond - A Functional & Integrative Perspective On Supporting the Immune System."   There will be ample time for questions towards the end of the interview.   Julie Bender-Sibbio RDN, LDN, cWC is a functional and integrative nutritionist who helps patients identify root cause solutions in order to restore hope, health, and vitality!  She passionately combines her conventional and integrative nutrition training and 20+ years of experience to help patients recover and thrive using a comprehensive and holistic approach that takes into account each person's unique biochemistry, genetics, lifestyle factors, diet, environment, and health history. Julie's private practice specializes in chronic gut dysfunction, autoimmune disease, food allergies/sensitives, and environmental illness.  Julie helps people reclaim good health and discover a PEACEFUL gut at JBS Nutrition & Wellness in Sarasota, FL, and online at jbsnourishwell.com.   She is passionate about educating our community and patients in this area, and it is the reason why she decided to specialize in gut-related disorders back in 2015.  "Every day, I meet patients/clients who have received poor or inaccurate medical advice or who have suffered needlessly with gut-related disorders for years and even decades."   She specializes in Celiac Disease, Irritable Bowel Syndrome, Chronic Constipation, SIBO, Diarrhea, Gastroparesis, Food Allergies/Sensitivities, Gastroesophageal Reflux Disease, Gluten Sensitivity, Inflammatory Bowel Disease, Leaky Gut, Autoimmune Disease, Thyroid Dysfunction, Mold/Biotoxin Illness, Vitamin Deficiencies, Yeast and fungal overgrowth.  

AGMD is honored to present an inspirational interview with Jaci Smith, whose sister, Billie Sweeney, was diagnosed with Gastroparesis in 1996 and passed away in 2016. Join us as Jaci talks about her experiences and her desire to carry out Billie's wish to draw awareness to Gastroparesis.  This program is sponsored by the Association of Gastrointestinal Motility Disorders, Inc. (AGMD). Please visit our website at www.agmdhope.org to learn more about AGMD's programs and resources.

This program is specifically for patients and loved ones living with and/or impacted by Gastroparesis.    We invite you to learn, share your questions, concerns, stories, and personal experiences, and give and receive support as, together, we learn to cope with the physical and emotional aspects of this often life-changing illness.

This program is specifically for patients and loved ones living with and/or impacted by Gastroparesis.    We invite you to learn, share your questions, concerns, stories, and personal experiences, and give and receive support as, together, we learn to cope with the physical and emotional aspects of this often life-changing illness.

The Association of Gastrointestinal Motility Disorders, Inc. | AGMD | is privileged to present an open discussion entitled, Coping with Holiday Pressures and Expectations. The holiday season can be one of the most physically, socially, emotionally, and financially challenging times of year for those living with digestive disorders.  Please join us as we discuss how to cope with the pressures and expectations associated with the holidays.

AGMD is privileged to present an Interview with Julie Bender-Sibbio, RDN, LDN, cWC. Julie is a functional and integrative nutritionist who helps patients identify root cause solutions in order to restore hope, health, and vitality!  She passionately combines her conventional and integrative nutrition training and 20+ years of experience to help patients recover and thrive using a comprehensive and holistic approach that takes into account each person’s unique biochemistry, genetics, lifestyle factors, diet, environment, and health history.   Julie's private practice is at JBS Nutrition and Wellness, LTD, where she specializes in Celiac Disease, Irritable Bowel Syndrome, Chronic Constipation, SIBO, Diarrhea, Gastroparesis, Food Allergies/Sensitivities, Gastroesophageal Reflux Disease, Gluten Sensitivity, Inflammatory Bowel Disease, Leaky Gut, Autoimmune Disease, Thyroid Dysfunction, Mold/Biotoxin Illness, Vitamin Deficiencies, Yeast and Fungal Overgrowth, and Chronic Illness. You can learn more about Julie and her practice at jbsnourishwell.com. During the interview, Julie will be talking about SIBO as well as other topics.  This program is sponsored by the Association of Gastrointestinal Motility Disorders, Inc. | AGMD |.

As part of Gastroparesis Awareness Month, AGMD is honored to present an Interview with Dr. Thomas Abell. Dr. Abell specializes in Gastrointestinal Motility Disorders with a specific interest in gastroparesis. He is currently at the University of Louisville. This program is sponsored by the Association of Gastrointestinal Motility Disorders, Inc. | AGMD |.

Parents with a child of any age suffering from a digestive motility disease or disorder need support. Our Telephone Internet Community Support Group program provides a forum for parents to share their questions, concerns, frustrations, and emotions with others who understand.

This program is specifically for patients and loved ones living with and/or impacted by Gastroparesis.  We invite you to learn, share your questions, concerns, stories, and personal experiences, and give and receive support as, together, we learn to cope with the physical and emotional aspects of this often life-changing illness. Sponsored by the Association of Gastrointestinal Motility Disorders, Inc. | AGMD |.

AGMD presents its Chronic Intestinal Pseudo-Obstruction (CIPO) Telephone Internet Community Support Group meeting. This forum provides a place for patients with CIPO as well as their family members, to voice their concerns, frustrations, share their experiences and gain much needed support. This program is sponsored by the Association of Gastrointestinal Motility Disorders, Inc. | AGMD |.

AGMD presents it's Newly Diagnosed Telephone Internet Community Support Group Meeting. When a patient is newly diagnosed with a digestive motility disorder, there are endless questions, fears and tears that may accompany trying to process the news. Patients and their families may go through a roller coaster of emotions. They may feel frightened and very much alone. All participants have given AGMD their consent to have their voices recorded should they decide to speak during the program. We encourage you to listen to the voices of those who are beginning their journies of living with a digestive motility disorder and those who are seasoned patients.

AGMD presents its Gastroparesis Telephone Internet Community Support Group meeting.  This program provides a forum for patients and their loved ones to share their questions, concerns and frustrations and receive much needed support. All participants gave AGMD their consent to be recorded if they chose to speak during the program. This program is sponsored by the Association of Gastrointestinal Motility Disorders, Inc. | AGMD |.

AGMD presents its Chronic Intestinal Pseudo-Obstruction (CIPO) Telephone Internet Community Support Group meeting. This forum provides a place for patients with CIPO as well as their family members, to voice their concerns, frustrations, share their experiences and gain much needed support. This program is sponsored by the Association of Gastrointestinal Motility Disorders, Inc. | AGMD |.

AGMD presents its Young Adult Telephone Internet Community Support Group meeting. This meeting is co-facilitated by Andrew Carbone, a young adult patient with chronic intestinal pseudo-obstruction, gastroparesis and gastroesophageal reflux disease.  All participants have consented to AGMD to have their voices recorded during the program should they decide to speak.

Parents with a child of any age suffering from a digestive motility disease or disorder need support. Our Telephone Internet Community Support Group program provides a forum for parents to share their questions, concerns, frustrations, and emotions with others who understand.

The Association of Gastrointestinal Motility Disorders, Inc. (AGMD) presents, Living With Digestive Motility Disorders. This open discussion meeting is for anyone affected by motility disease, including patients, parents, partners, and loved ones.  AGMD provides a safe place to talk about everything that goes along with the diagnosis of a motility disease.  Topics include emotional/mental health issues, chronic pain, relationships (personal as well as with medical professionals) ostomies, tubes, lines, and nutrition. This program is co-facilitated by Brittany Neal. Brittany is a patient with chronic idiopathic pseudo-obstruction since birth. Now in her 30s, she has had numerous surgeries and procedures including multiple central liine placements, G and J-tubes, and has a permanent ileostomy. She is currently TPN dependent and has several health concerns due to CIPO. No longer able to work, she serves as a volunteer for AGMD. Since the publication of this program, we sadly report that Brittany Neal passed away in February 2018. She is greatly missed. We honor her memory by posting this program. It reflects her caring heart and unconditional dedication and willingness to help others.

AGMD presents it's Newly Diagnosed Telephone Internet Community Support Group Meeting. When a patient is newly diagnosed with a digestive motility disorder, there are endless questions, fears and tears that may accompany trying to process the news. Patients and their families may go through a roller coaster of emotions. They may feel frightened and very much alone. All participants have given AGMD their consent to have their voices recorded should they decide to speak during the program. We encourage you to listen to the voices of those who are beginning their journies of living with a digestive motility disorder and those who are seasoned patients.

AGMD presents its Chronic Intestinal Pseudo-Obstruction (CIPO) Telephone Internet Community Support Group meeting. This forum provides a place for patients with CIPO as well as their family members, to voice their concerns, frustrations, share their experiences and gain much needed support. All program participants have given their consent to AGMD for their voices to be recorded should they decide to speak during the program.

AGMD presents its Young Adult Telephone Internet Community Support Group meeting. This meeting is co-facilitated by Andrew Carbone, a young adult patient with chronic intestinal pseudo-obstruction, gastroparesis and gastroesophageal reflux disease.  All participants have consented to AGMD to have their voices recorded during the program should they decide to speak.

Parents with a child of any age suffering from a digestive motility disease or disorder need support. Our Telephone Internet Community Support Group program provides a forum for parents to share their questions, concerns, frustrations, and emotions with others who understand. All participants gave their permission for their voices to be recorded if they chose to speak during the program.

The Association of Gastrointestinal Motility Disorders, Inc. (AGMD) presents, Living With Digestive Motility Disorders. This open discussion meeting is for anyone affected by motility disease, including patients, parents, partners, and loved ones.  AGMD provides a safe place to talk about everything that goes along with the diagnosis of a motility disease.  Topics include emotional/mental health issues, chronic pain, relationships (personal as well as with medical professionals) ostomies, tubes, lines, and nutrition. This program is co-facilitated by Brittany Neal. Brittany is a patient with chronic idiopathic pseudo-obstruction since birth. Now in her 30s, she has had numerous surgeries and procedures including multiple central liine placements, G and J-tubes, and has a permanent ileostomy. She is currently TPN dependent and has several health concerns due to CIPO. No longer able to work, she serves as a volunteer for AGMD. Since the publication of this program, we sadly report that Brittany Neal passed away in February 2018. She is greatly missed. We honor her memory by posting this program. It reflects her caring heart and unconditional dedication and willingness to help others.

AGMD Presents its Patient Telephone Internet Community Support Group meeting.  This forum provides a place for patients as well as their family members, to voice their concerns, frustrations, share their experiences and gain much needed support. All program participants have given their consent to AGMD for their voices to be recorded should they decide to speak during the program. Sponsored by the Association of Gastrointestinal Motility Disorders, Inc. | AGMD |

AGMD presents its Gastroparesis Telephone Internet Community Support Group meeting.  This program provides a forum for patients and their loved ones to share their questions, concerns and frustrations and receive much needed support. All participants gave AGMD their consent to be recorded if they chose to speak during the program.

AGMD presents its Chronic Intestinal Pseudo-Obstruction (CIPO) Telephone Internet Community Support Group meeting. This forum provides a place for patients with CIPO as well as their family members, to voice their concerns, frustrations, share their experiences and gain much needed support. All program participants have given their consent to AGMD for their voices to be recorded should they decide to speak during the program.

AGMD Presents its Patient Telephone Internet Community Support Group meeting.  This forum provides a place for patients as well as their family members, to voice their concerns, frustrations, share their experiences and gain much needed support. All program participants have given their consent to AGMD for their voices to be recorded should they decide to speak during the program.

The Association of Gastrointestinal Motility Disorders (AGMD) is privileged to present An interview featuring Jaime, a parent who has a child with Hirschsprung's Disease. During the program, Jaime chronicles her heart-warming and moving journey as she describes life with a child having Hirschsprung's Disease. Sponsored by the Association of Gastrointestinal Motility Disorders, Inc. (AGMD).

AGMD presents its Chronic Intestinal Pseudo-Obstruction (CIPO) Telephone Internet Community Support Group meeting. This forum provides a place for patients with CIPO as well as their family members, to voice their concerns, frustrations, share their experiences and gain much needed support. All program participants have given their consent to AGMD for their voices to be recorded should they decide to speak during the program.

AGMD presents its Gastroparesis Telephone Internet Community Support Group meeting.  This program provides a forum for patients and their loved ones to share their questions, concerns and frustrations and receive much needed support. All participants gave AGMD their consent to be recorded if they chose to speak during the program.

AGMD presents its Chronic Intestinal Pseudo-Obstruction (CIPO) Telephone Internet Community Support Group meeting. This forum provides a place for patients with CIPO as well as their family members, to voice their concerns, frustrations, share their experiences and gain much needed support. All program participants have given their consent to AGMD for their voices to be recorded should they decide to speak during the program.